KOKhawaja O. Omar

Khawaja O. Omar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Khawaja O. Omar has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Blastomycosis in a Renal Transplant Recipient: A Rare Encounter in Rural Appalachia

    by Khawaja O. Omar, William Sebastian, Suzanne Kemper

    Background: Blastomycosis is a fungal infection caused by Blastomyces species, which are thermally dimorphic fungi endemic to the midwestern, south-central, and southeastern United States (US). Organ transplant patients are at risk of infection due to long-term immunosuppressive therapy. We present a unique case of blastomycosis in a renal transplant patient residing in a non-endemic region of Appalachia. Case Report: A 67-year-old patient with history of tobacco use, atrial fibrillation, type 2 diabetes, hyperlipidemia, and bilateral deceased donor kidney transplantation (DDKT) in 2021, presented to Charleston Area Medical Center’s (CAMC), Charleston WV, Emergency Department (ED) for fever and night sweats. Initial workup revealed 39.4℃ temperature with remaining vital signs normal. Corona, parainfluenza, influenza, metapneumovirus, mycoplasma pneumonia, RSV were negative, GI PCR panel was negative for C. difficle, yersinia, campylobacter, giardia, vibrio, norovirus, salmonella, rotavirus. Chest X-ray showed a 2.1 x 1.6cm nodular density in the left upper lung (LUL) lobe. White blood cell (WBC) count was elevated at 13000/mcl with a left-sided shift. Subsequent computed tomography (CT) of the chest without contrast demonstrated a 2.7 x 2.1cm LUL mass. Urine Blastomyces antigen tested positive, prompting the initiation of empiric therapy for blastomycosis. Aspergillus was ruled out initially. Conclusion: Blastomycosis is a rare occurrence in the US, with annual incidence reported at 1 to 2 cases per 100,000. While transplant recipients are predisposed to acquiring blastomycosis, it remains an infrequent occurrence. In transplant patients presenting with persistent infectious symptoms, blastomycosis and other rare etiologies should be considered to prevent severe complications.

  • Open Access

    Reversible Cerebral Vasoconstriction Syndrome Induced by Sumatriptan: A Case Report and Review of Literature.

    by Rafi Aibani, Morgan Koontz, James Stephen Harman, Amir Kamran, Khawaja Omar

    Background Reversible Cerebral Vasoconstriction Syndrome (RCVS) is characterized by multiple transient cerebral vasoconstrictions that typically resolve within three months, often presenting with sudden thunderclap headaches. Although the cause can be identified in 25% to 60% of cases, RCVS can also occur spontaneously. Common triggers include vasoactive substances and postpartum states, with the latter accounting for 50% to 60% of cases. This report discusses a case of RCVS following sumatriptan use. Case Report. A 58-year-old woman with controlled hypertension and obstructive sleep apnea presented with recurrent unilateral pulsating headaches, nausea, and photophobia. Initially diagnosed as migraine, she later developed right homonymous hemianopia. Imaging revealed bilateral occipital and parietal strokes with intracranial vasoconstriction. Cerebral angiography confirmed vasospasm, responsive to intra-arterial milrinone. Diagnosed with reversible cerebral vasoconstriction syndrome, she was treated with nimodipine, resulting in complete symptom resolution. Conclusion RCVS is a rare syndrome with varied triggers and clinical features, requiring careful evaluation and management. Early diagnosis and vasospasm-targeted therapies, such as nimodipine, are essential for preventing complications. This case underscores the importance of considering RCVS in patients with sudden severe headaches and neurological deficits, particularly those using serotonergic medications


  • Open Access

    Rare Case of Idiopathic Thrombocytopenia Causing Retrobulbar Hemorrhage

    by Khawaja O Omar, William Sebastian, Amna Anees

    Immune thrombocytopenia purpura (ITP) is defined as a platelet count lower than 100 x 10^9/L, in the absence of known abnormalities in white blood cells, normal hemoglobin with generalized purpuric rash: making it a diagnosis of exclusion.1-2 ITP is due to destruction of platelets in the spleen via autoantibodies, resulting in reduced platelet counts.3 Though rare, ITP is linked with spontaneous retrobulbar hemorrhage (SRH). If ITP is identified, prompt treatment is needed to prevent loss of vision. An 80-year-old non-smoking woman with a history of diabetes, hypertension, and alpha thalassemia minor presented with a one-day history of a right occipital lobe headache and right sided ocular dysfunction. Workup showed a very low platelet count of 35,000/mm3, and elevated D-Dimer at 12,485 ng/mL. MRI revealed a new hemorrhage in the retrobulbar area causing right-sided proptosis. MRA showed no arteriovenous shunting, and the right ophthalmic artery was patent. Therapy for seven days with cryoprecipitate, IVIG, and steroids was started, symptoms resolved, and patient was discharged. The relationship between ITP and non-traumatic subperiosteal orbital hemorrhage (NTSOH) is unclear, but its occurrence in the setting of anemia is often seen. To best of our knowledge this is a rare case of NTSOH in a patient with mild anemia and acute ITP in the absence of other risk factors such as trauma or excessive Valsalva events.

  • Open Access

    Postpartum Acquired Hemophilia A

    by Khawaja O Omar, William Sebastian, Suzanne Kemper

    Acquired hemophilia A (AHA) is a bleeding disorder that occurs from aberrant production of autoantibodies that target factor VIII. The underlying cause of AHA is unclear but can present postpartum. Very few cases have reported instances of AHA coexisting with other hematological disorders, such as sickle cell trait (SCT). Although rare and no direct correlation between the two, critical situations involving intractable bleeding can intensify the severity of these disorders. A 31-year-old pregnant female with a medical history significant for SCT presented to the hospital for a C-section. Shortly after the procedure she experienced intractable bleeding from multiple sites. Initial lab work yielded an isolated increase in activated partial thromboplastin time (aPTT). Further investigation showed abnormal mixing studies, reduced factor VIII activity and the presence of factor VIII antibodies. The patient was diagnosed with postpartum AHA (PAH) and treated with activated Factor VII and prednisone. PAH is an uncommon bleeding disorder that commonly occurs one to four months postpartum and presents as excessive bleeding elevated aPTT, abnormal mixing studies, and reduced factor VIII levels with abnormally high inhibitor levels. Despite an unknown identifiable etiology, treatment hinges upon establishing hemostasis and eradicating the aberrant generated factor VIII inhibitors. The association of AHA and other hematological disorders is not yet elucidated.

  • Open Access

    A Rare Case of Donor-Derived Renal Cell Carcinoma in a Kidney Transplant Recipient

    by William Sebastian, Khawaja O. Omar, Rabia Anees, Santosh Nagaraju, Mishra Chaitanya

    BACKGROUND The incidence of renal cell carcinoma (RCC) in transplanted kidneys is reported to be about 0.2%, which makes this case exceedingly rare. Risk factors include older age of the donors, smoking, obesity, and hypertension. Higher incidences of allograft RCC have been seen in patients who received a kidney from a deceased donor rather than from a living donor. CASE REPORT A 71-year-old woman with end-stage renal disease underwent deceased donor kidney transplantation (DDKT) 1 year before presentation. The immune-suppressive regimen was Envarsus, Myfortic, and prednisone. Allograft functioned with a baseline creatinine of 1.4-1.5 mg/dL. The patient presented due to recurring UTIs, which prompted the ultrasound that showed a mass on the allograft. Abdominal MRI demonstrated a 3.5-cm mass in the upper pole. Biopsy showed clear-cell RCC, Fuhrman nuclear grade 3. The patient underwent a partial nephrectomy. Following the nephrectomy, baseline serum creatinine was 1.7-2 mg/dL. The patient was discharged with immunosuppressive therapy consisting of Myfortic, prednisone, and Rapamune after diagnosis. CONCLUSIONS There are no standard treatment guidelines or optimal immune therapy for the management of allograft RCC in renal transplant recipients. Options include radical nephrectomy, nephron-sparing surgery (NSS), radiofrequency ablation (RFA), and active surveillance. According to a systematic review, the recurrence of cancer after partial nephrectomy was 3.6% after 3.1 years, which was similar to non-transplanted kidneys. There is not enough evidence to support screening for RCC in patients with transplanted kidneys, but constitutional symptoms like recurrent UTIs should prompt further investigation for potential malignancies in these patients.